Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance

[1]  Tim Reed,et al.  Civil society engagement in multi-stakeholder dialogue: a qualitative study exploring the opinions and perceptions of MeTA members , 2017, Journal of pharmaceutical policy and practice.

[2]  M. Tanner,et al.  Combating poor-quality anti-malarial medicines: a call to action , 2016, Malaria Journal.

[3]  T. Eckmanns,et al.  What influences availability of medicines for the community management of childhood illnesses in central Uganda? Implications for scaling up the integrated community case management programme , 2015, BMC Public Health.

[4]  Domenico Dentoni,et al.  The role(s) of universities in dealing with global wicked problems through multi-stakeholder initiatives , 2015 .

[5]  J. Fox,et al.  Assessing the Evidence: The Effectiveness and Impact of Public Governance-Oriented Multi-Stakeholder Initiatives , 2015 .

[6]  S. Rose-Ackerman,et al.  Corruption in the Procurement of Pharmaceuticals and Medical Equipment in China: The Incentives Facing Multinationals, Domestic Firms and Hospital Officials , 2014 .

[7]  Thomas Schillemans,et al.  The Accountability Cube: Measuring Accountability , 2013 .

[8]  J. Kohler,et al.  Good governance for medicines initiatives: Exploring lessons learned , 2013 .

[9]  A. Ghaffar,et al.  Access to medicines from a health system perspective , 2012, Health policy and planning.

[10]  G. Palazzo,et al.  Input and output legitimacy of multi-stakeholder initiatives , 2012 .

[11]  C. Báez.  Using power and influence analysis to address corruption risks The case of the Ugandan drug supply chain , 2012 .

[12]  D. Ross-Degnan,et al.  Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. , 2011, Health policy.

[13]  D. Brinkerhoff,et al.  Accountability and health systems: toward conceptual clarity and policy relevance. , 2004, Health policy and planning.

[14]  Gale,et al.  Qualitative Data Analysis: An Expanded Sourcebook , 1994 .

[15]  Maria Cucciniello,et al.  25 Years of Transparency Research: Evidence and Future Directions , 2017 .

[16]  D. Buchanan.  Case Studies in Organizational Research , 2012 .

[17]  N. Juban,et al.  Philippines Pharmaceutical Situation 2009 WHO Household Survey on medicines , 2010 .

[18]  Contributions from M. Walpole.  The Millennium Development Goals Report , 2008 .

[19]  Gillian Symon,et al.  Qualitative methods in organizational research : a practical guide , 1994 .

[20]  M. Patton.  Qualitative research and evaluation methods , 1980 .